TELA
Tela Bio Inc
NASDAQ: TELA · HEALTHCARE · MEDICAL DEVICES
$0.87
+1.72% today
Updated 2026-04-30
Market cap
$34.90M
P/E ratio
—
P/S ratio
0.44x
EPS (TTM)
$-0.83
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Tela Bio Inc (TELA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.25M | $8.27M | $15.45M | $18.21M | $29.46M | $41.42M | $58.45M | $69.30M | $80.28M |
| Revenue growth (YoY) | — | +94.9% | +86.7% | +17.9% | +61.8% | +40.6% | +41.1% | +18.6% | +15.8% |
| Cost of revenue | $1.71M | $5.33M | $6.17M | $6.98M | $10.65M | $14.37M | $18.34M | $22.81M | $25.93M |
| Gross profit | $2.53M | $2.94M | $9.27M | $11.23M | $18.81M | $27.04M | $40.11M | $46.49M | $54.34M |
| Gross margin | 59.6% | 35.6% | 60.0% | 61.7% | 63.9% | 65.3% | 68.6% | 67.1% | 67.7% |
| R&D | $5.79M | $4.34M | $4.15M | $4.25M | $6.74M | $8.94M | $9.62M | $8.81M | $9.22M |
| SG&A | $4.96M | $4.90M | $6.22M | $10.14M | $12.46M | $13.86M | $14.89M | $14.72M | $15.69M |
| Operating income | $-16.92M | $-17.78M | $-19.16M | $-25.27M | $-29.45M | $-39.01M | $-44.08M | $-34.12M | $-33.76M |
| Operating margin | -398.7% | -214.9% | -124.1% | -138.8% | -100.0% | -94.2% | -75.4% | -49.2% | -42.0% |
| EBITDA | $-16.02M | $-18.04M | $-18.23M | $-24.70M | $-29.14M | $-39.06M | $-40.63M | $-31.68M | $-33.76M |
| EBITDA margin | -377.3% | -218.1% | -118.0% | -135.6% | -98.9% | -94.3% | -69.5% | -45.7% | -42.0% |
| EBIT | $-16.78M | $-19.29M | $-18.82M | $-25.23M | $-29.68M | $-40.24M | $-41.44M | $-32.70M | — |
| Interest expense | $4.56M | $1.80M | $3.61M | $3.56M | $3.60M | $4.05M | $5.22M | $5.29M | $5.25M |
| Income tax | $4.65M | $-1.51M | $3.38M | $3.08M | $2.83M | $41000.00 | $640105.00 | $-144000.00 | — |
| Effective tax rate | -27.9% | 6.7% | -17.7% | -12.0% | -9.3% | -0.1% | -1.4% | 0.4% | 0.0% |
| Net income | $-21.33M | $-21.09M | $-22.43M | $-28.79M | $-33.28M | $-44.30M | $-46.66M | $-37.84M | $-38.83M |
| Net income growth (YoY) | — | +1.1% | -6.3% | -28.4% | -15.6% | -33.1% | -5.3% | +18.9% | -2.6% |
| Profit margin | -502.6% | -254.9% | -145.2% | -158.1% | -112.9% | -106.9% | -79.8% | -54.6% | -48.4% |